A case of Dili-drug induced liver injury by norethisterone combined with mifepristone

Authors

  • Chaitanya Indrani Department of Obstetrics and Gynaecology, MVJ Medical College and Research Hospital, Hoskote, Bangalore, Karnataka, India
  • Anjali Antony Department of Obstetrics and Gynaecology, MVJ Medical College and Research Hospital, Hoskote, Bangalore, Karnataka, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20250547

Keywords:

Acute liver injury, Progesterone, Mifepristone

Abstract

DILI related to female sex hormones like estrogen and progesterone generally occur with estrogen component. Progesterone related DILI are not commonly reported. We are reporting a case of DILI by norethisterone combined with mifepristone in a 37-year-old woman. Oral contraceptives have been shown to be associated with variety of liver injuries. Various manifestations include hepatitis, cholestatisis, hepatic adenoma, peliosis hepatitis, sinusoidal obstruction syndrome and increase in size of pre-existing hemangiomas. It is important to create awareness about norethisterone-induced liver injury among clinicians, especially gynaecologists and also use combination drugs after studying the mechanism of action, agonistic and antagonistic actions.

Metrics

Metrics Loading ...

References

Shah I, Putnam T, Daugherty E, Vyas N, Chuang KY. Mifepristone: an uncommon cause of drug-induced liver injury. Gastroenterology Res. 2019;12(3):181-4. DOI: https://doi.org/10.14740/gr1188

I Shah, T Putnam. Correction to: Mifepristone: An uncommon cause of drug induced liver injury. Gastroenterol Res. 2020;13(4):161-2. DOI: https://doi.org/10.14740/gr1188c1

Downloads

Published

2025-02-26

How to Cite

Indrani, C., & Antony, A. (2025). A case of Dili-drug induced liver injury by norethisterone combined with mifepristone. International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 14(3), 979–980. https://doi.org/10.18203/2320-1770.ijrcog20250547

Issue

Section

Case Reports